Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 540-543

  Scorpio, Angelo ^a   Lindholm Levy, Pamela ^b   Heifets, Leonid ^b   Gilman, Robert ^a   Siddiqi, Salman ^c   Cynamon, Michael ^d   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c BD Technologies   (United States)

^d SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAZINAMIDE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0031020486     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.540     Document Type: Article

References (28)

1. Bloom, B. R., and C. J. L. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055-1064.
2. British Thoracic Association. 1984. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. Br. J. Dis. Chest 78:330-336.
3. Butler, W. R., and J. O. Kilburn. 1983. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob. Agents Chemother. 24:600-601.
4. Centers for Disease Control. 1991. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. Morbid. Mortal. Weekly Rep. 40:585-591.
5. Heifets L., and P. Lindholm-Levy. 1992. Pyrazinamide sterilizing activity in vitro against semi-dormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 145:1223-1225.
6. Heifets, L. B. 1991. Drug susceptibility in the chemotherapy of mycobacterial infections, p. 89-122. In L. B. Heifets (ed.), Drug susceptibility tests in the management of chemotherapy of tuberculosis. CRC Press, Inc., Boca Raton, Fla.
7. Hewlett D., D. L. Horn, and C. Alfalla. 1995. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 273:916-917.
8. Hong Kong Chest Service/British Medical Research Council. 1981. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet i:171-174.
9. Klemens, S. P., C. A. Sharpe, and M. H. Cynamon. 1996. Activity of pyrazinamide in a murine model against. Mycobacterium tuberculosis isolates with various levels of in vitro susceptibility. Antimicrob. Agents Chemother. 40: 14-16.
10. Konno, K., F. M. Feldman, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95: 461-469.
11. Mackaness, G. B. 1956. The intracellular activation of pyrazinamide and nicotinamide. Am. Rev. Tuberc. 74:718-728.
12. McClatchy, J. K., A. Y. Tsang, and M. S. Cernich. 1981. Use of pyrazinamidase activity in Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agents Chemother. 20: 556-557.
13. McCune, R. M., R. Tompsett, and W. McDermott. 1956. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by administration of pyrazinamide and a companion drug. J. Exp. Med. 104:763-802.
14. McDermott, W., and R. Tompsett. 1954. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am. Rev. Tuberc. 70:748-754.
15. Miller, M., L. Thibert, F. Desjardins, S. Siddiqi, and A. Dascal. 1995. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of BACTEC method with pyrazinamidase assay. J. Clin. Microbiol. 33:2468-2470.
16. Mitchison, D. A. 1985. The action of antituberculosis drugs in short course chemotherapy. Tubercle 66:219-225.
17. Orita, M., Y. Suzuki, T. Sekiya, and K. Hayashi. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
18. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-191.
19. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Med. 2:662-667.
20. Scorpio, A., D. M. Collins, D. Whipple, D. Cave, J. Bates, and Y. Zhang. 1997. Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. J. Clin. Microbiol. 32:106-110.
21. Siddiqui, S. H. 1992. Antimicrobial susceptibility testing: radiometric (BACTEC) tests for slowly growing mycobacteria, p. 14-25. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook. ASM Press, Washington, D.C.
22. Singapore Tuberculosis Service/British Medical Research Council. 1981. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months. Tubercle 62:95-102.
23. Snider, D. E., J. Rogowski, M. Zierski, E. Bek, and M. W. Long. 1982. Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months. Am. Rev. Respir. Dis. 125:265-267.
24. Tarshis, M. S., and W. A. Weed. 1953. Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media. Am. Rev. Tuberc. 67:391-395.
25. Trivedi, S. S., and S. G. Desai. 1987. Pyrazinamidase activity of Mycobacterium tuberculosis - a test of sensitivity to pyrazinamide. Tubercle 68:221-224.
26. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
27. Yeager, R. L., W. G. Munroe, and F. I. Dessau. 1952. Pyrazinamide (Aldinamide) in the treatment of pulmonary tuberculosis. Am. Rev. Tuberc. 65: 523-534.
28. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (London) 358:591-593.